spacer
Eyepea Management Services - Intellectual Property ServicesIntellectual Property Management Service. A Registered Trademark Agent » Bookmark this page
IP Services
Home
Trademark Search
Trademark Registration
Trademark Renewal
Trademark Assignment
Request for Service
IP Resources
Intellectual Property
Trademark
Copyright
Patent
Book Store
TM Common Terms
Nice Classification
About Eyepea
Contact Us
About Us
 
IP & Trademark Related Book List
Keyword    (e.g. how to patent)


Book List: pharmaceutical patent

Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
Millennium in-licenses novel oncology program from Xenova.(New treatment of solid tumors in cancer): An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Sepracor awarded patents for insomnia treatment.: An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


GenVec signs contract for preventative AIDS vaccine.(3-year contract has estimated value of $10.2 mn)(Government Activity)(Product Development)(Brief Article): An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Genmab and Paradigm announce major alliance.(Paradigm Therapeutics; antibody development collaboration)(Brief Article): An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Patent issued to Infimed for its controlled release protein delivery technology.: An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Resveratrol: Thousands of Bottles of Wine, High-Dose Pills Not Required.: An article from: BIOTECH Patent News
Offer Price: USD $9.95
Author: Gale Reference Team
Publisher: Biotech Patent News


Sirna Therapeutics granted two key patents on its RNA interference technology.: An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Biotech Holdings reports on patent-related diabetes drug and OTC business.(Brief Article): An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


AlphaRx completes lyophilization process for Zysolin.: An article from: BIOTECH Patent News
Offer Price: USD $9.95
Author: Unavailable
Publisher: Biotech Patent News


Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement.: An article from: BIOTECH Patent News
Offer Price: USD $9.95
Author: Unavailable
Publisher: Biotech Patent News


Generex Biotechnology receives Japanese patent for technology to enhance T helper cell recognition of cancer and bioterrorism antigens.: An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


ID Biomedical begins trivalent nasal flu vaccine study.(Vaccine for prevention of influenza)(Brief Article): An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Alnylam licenses RNA interference patents.: An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Arcus patents diagnostic and imaging uses of vascular targeting agent technology.(Brief Article): An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


CytRx acquires product license for breakthrough DNA-based HIV vaccine-.: An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Antares Pharma Announces Notice of Allowance.(Easy Tec fast-melt tablet technology): An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Genzyme files suit against TKT for glucocerebrosidase patent infringement.(Gaucher disease): An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Valentis clinical trial of an intravenous IL-2 gene medicine for lung cancer is underway.(Brief Article): An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Peregrine and Affitech to collborate on developing antibodies.: An article from: BIOTECH Patent News
Offer Price: USD $5.95
Publisher: Biotech Patent News


Anadys Initiates Phase I Clinical Trial of Non-Nucleoside Polymerase Inhibitor for Treatment of Hepatitis C.: An article from: BIOTECH Patent News
Offer Price: USD $9.95
Author: Gale Reference Team
Publisher: Biotech Patent News


Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |

spacer

Eyepea Management Services is now part of Intellect Front. Based in Malaysia, Singapore, and U.S., Intellect Front specializes in trademark & intellectual property portfolio management.
© 2012 Intellect Front. All Rights Reserved. Privacy Policy
Powered by Genuine Technology
spacer